A RANDOMIZED, OPEN, COMPARATIVE MULTICENTER STUDY OF INITIAL TREATMENT WITH INTRAVENOUS ITRACONAZOLE VERSUS AMPHOTERICIN B FOLLOWED BY CONSOLIDATION TREATMENT WITH ITRACONAZOLE CAPSULES IN PATIENTS WITH BLASTOMYCOSIS OR HISTOPLASMOSIS: